doi: 10.1155/2009/181927.
Epub 2009 Jan 26.
Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter
Affiliations
- PMID: 19190765
- PMCID: PMC2630418
- DOI: 10.1155/2009/181927
Item in Clipboard
Retroperitoneal lymph nodes in transitional cell carcinoma of the kidney and ureter
Adv Urol.
2009.
Abstract
The incidence of transitional cell carcinoma of the kidney and ureter is low and for that reason limited data exists regarding the appropriate management of regional retroperitoneal lymph nodes. Lymph node metastases have consistently been associated with an adverse prognosis. However, five-year cancer-specific survival following nephroureterectomy and lymphadenectomy for patients with lymph node involvement ranges from 0-39%, suggesting a therapeutic benefit. This review covers the primary tumor characteristics associated with lymph node involvement, imaging of the lymph nodes, as well as the rationale, role, patient selection, suggested anatomic templates, and technical considerations for lymphadenectomy.
Similar articles
-
Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.J Urol. 2015 Dec;194(6):1567-74. doi: 10.1016/j.juro.2015.06.077. Epub 2015 Jun 19. J Urol. 2015. PMID: 26094807 Free PMC article.
-
Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).Urol Oncol. 2016 Dec;34(12):531.e15-531.e24. doi: 10.1016/j.urolonc.2016.06.013. Epub 2016 Jul 27. Urol Oncol. 2016. PMID: 27476032 Free PMC article.
-
Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma.World J Urol. 2017 Apr;35(4):535-548. doi: 10.1007/s00345-016-1764-z. Epub 2016 Jan 25. World J Urol. 2017. PMID: 26809456 Review.
-
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?J Urol. 2003 Jun;169(6):2113-7. doi: 10.1097/01.ju.0000067601.29966.4a. J Urol. 2003. PMID: 12771730 Clinical Trial.
-
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer.Eur Urol Focus. 2019 Mar;5(2):224-241. doi: 10.1016/j.euf.2017.09.015. Epub 2017 Nov 20. Eur Urol Focus. 2019. PMID: 29158169
Cited by
-
Effects of tumor size and location on survival in upper tract urothelial carcinoma after nephroureterectomy.Indian J Urol. 2018 Jan-Mar;34(1):68-73. doi: 10.4103/iju.IJU_216_17. Indian J Urol. 2018. PMID: 29343916 Free PMC article.
-
Investigating the flow dynamics in the obstructed and stented ureter by means of a biomimetic artificial model.PLoS One. 2014 Feb 3;9(2):e87433. doi: 10.1371/journal.pone.0087433. eCollection 2014. PLoS One. 2014. PMID: 24498322 Free PMC article.
References
-
- American Cancer Society. Cancer Facts & Figures 2007. Atlanta, Ga, USA: American Cancer Society; 2007.
-
- Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA: A Cancer Journal for Clinicians. 2005;55(1):10–30. - PubMed
-
- Huben RP, Mounzer AM, Murphy GP. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer. 1988;62(9):2016–2020. - PubMed
-
- Herr HW, Donat SM. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. The Journal of Urology. 2001;165(1):62–64. - PubMed
-
- Lerner SP, Skinner DG, Lieskovsky G, et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. The Journal of Urology. 1993;149(4):758–765. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
